Immunity Against Chlamydia Trachomatis
E. Marks, N. Lycke
Published 2008 · Medicine
Download PDFAnalyze on Scholarcy
Chlamydia trachomatis, the etiology of one of the most common human infections, is responsible for an increasing number of genital tract infections world-wide. In addition, this obligate intracellular pathogen infects epithelial cells of the eye, resulting in trachoma and, as a sequela, blindness. The genital tract infection often leads to severe damage of the reproductive tract, resulting in tubal factor infertility. Infection of the genital tract stimulates a complex array of host immune responses involving innate as well as adaptive immune responses. Cells of the innate immune system recognize and limit the spread of infection, and influence the outcome of infection through the modulation of the adaptive immune response. Protective immunity against C. trachomatis involves primarily Th1 CD4+ T cells and IFN-γ production, while antibodies, and possibly CD8+ T cells, can contribute to protection. However, the immune response to infection is complex and those components that convey protective immunity may contribute to the pathogenesis. Therefore, it is believed that a balance between Th1/Th2 effector and regulatory T cell populations is required to avoid harmful immunopathology and permanent sequelae. Advances in our understanding of the immunobiology of the genital tract and better knowledge about chlamydial infections are key issues for the development of effective vaccines. In this context, identifying protective chlamydial antigens is crucial as well as investigating optimal immunization routes and vaccine formulations, including choice of adjuvant, will probably be central to an effective anti-chlamydial vaccine. In the present chapter, we discuss the current knowledge of correlates of protection and vaccine strategies.
This paper references
Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge.
S. Pal (2003)
Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity.
L. Ågren (1999)
Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin.
J. Ngan (1978)
Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection.
K. Kelly (1996)
Comparison of Gamma Interferon-Mediated Antichlamydial Defense Mechanisms in Human and Mouse Cells
C. Roshick (2006)
An intermolecular mechanism of T cell help for the production of antibodies to the bacterial pathogen, Chlamydia trachomatis.
J. E. Allen (1993)
A novel concept in mucosal adjuvanticity: The CTA1‐DD adjuvant is a B cell‐targeted fusion protein that incorporates the enzymatically active cholera toxin A1 subunit
L. Ågren (1998)
Stimulation of the cytosolic receptor for peptidoglycan, Nod1, by infection with Chlamydia trachomatis or Chlamydia muridarum
Lynn Welter-Stahl (2006)
Chlamydia trachomatis and male infertility in Tunisia
R. Gdoura (2001)
Chemokine Expression Patterns Differ within Anatomically Distinct Regions of the Genital Tract during Chlamydia trachomatis Infection
H. Maxion (2002)
Impairment of natural killer cell activity in Chlamydia trachomatis infected individuals.
E. Mavoungou (1999)
Immune privilege in the gut: the establishment and maintenance of non‐responsiveness to dietary antigens and commensal flora
Onyinye I. Iweala (2006)
Microbiological and histopathological findings in acute pelvic inflammatory disease
J. Paavonen (1987)
Role for Inducible Nitric Oxide Synthase in Protection from Chronic Chlamydia trachomatis Urogenital Disease in Mice and Its Regulation by Oxygen Free Radicals
K. Ramsey (2001)
Pelvic inflammatory disease.
W. McCormack (1994)
CD8+ T cells in human uterine endometrial lymphoid aggregates: evidence for accumulation of cells by trafficking
G. R. Yeaman (2001)
The molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide.
J. Igietseme (1996)
Critical role of CD28 in protective immunity against Salmonella typhimurium.
H. Mittrücker (1999)
Chlamydia trachomatis-induced death of human spermatozoa is caused primarily by lipopolysaccharide.
S. Hosseinzadeh (2003)
Acrosome reaction in Chlamydia‐positive and negative patients
A. Jungwirth (2003)
Differential Kinetics and Distribution of Antibodies in Serum and Nasal and Vaginal Secretions after Nasal and Oral Vaccination of Humans
A. Rudin (1998)
The CD14 functional gene polymorphism -260 C>T is not involved in either the susceptibility to Chlamydia trachomatis infection or the development of tubal pathology
S. Ouburg (2005)
CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus.
M. Exley (2001)
Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.
G. Douce (1995)
The major outer membrane protein of Chlamydia trachomatis: critical binding site and conformation determine the specificity of antibody binding to viable chlamydiae.
J. Conlan (1989)
Expression of mitochondrial heat shock protein 60 in distinct cell types and defined stages of rat seminiferous epithelium.
A. Meinhardt (1995)
Induction of mucosal immune responses in the human genital tract.
J. Mestecky (2000)
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
F. Harding (1992)
Dendritic Cells Pulsed with a Recombinant Chlamydial Major Outer Membrane Protein Antigen Elicit a CD4+ Type 2 Rather than Type 1 Immune Response That Is Not Protective
J. Shaw (2002)
Identification ofChlamydia pneumoniae-specific protein antigens in immunoblots
H. Freidank (2005)
IFN-gamma-mediated antimicrobial response. Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth.
S. Thomas (1993)
Monocytes Heterozygous for the Asp299Gly and Thr399Ile Mutations in the Toll-like Receptor 4 Gene Show No Deficit in Lipopolysaccharide Signalling
C. Erridge (2003)
A Chlamydia trachomatis-Specific Th2 Clone Does Not Provide Protection against a Genital Infection and Displays Reduced Trafficking to the Infected Genital Mucosa
R. A. Hawkins (2002)
A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo.
S. Knight (1995)
Identification and distribution of the costimulatory receptor CD28 in the mouse.
J. Gross (1992)
Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection.
A. D. Murdin (2000)
Inducible Nitric Oxide Synthase Does Not Affect Resolution of Murine Chlamydial Genital Tract Infections or Eradication of Chlamydiae in Primary Murine Cell Culture
K. Ramsey (1998)
Do host genetic traits in the bacterial sensing system play a role in the development of Chlamydia trachomatis-associated tubal pathology in subfertile women?
J. den Hartog (2006)
HPV vaccine MedImmune/GlaxoSmithKline.
A. Billich (2003)
CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2
X. Tai (2005)
Population-based study of chlamydial infection in China: a hidden epidemic.
William L. Parish (2003)
Male serum Chlamydia trachomatis IgA and IgG, but not heat shock protein 60 IgG, correlates with negatively affected semen characteristics and lower pregnancy rates in the infertile couple.
A. Idahl (2007)
Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors
J. Riley (2002)
A Predominant Role for Antibody in Acquired Immunity to Chlamydial Genital Tract Reinfection1
S. Morrison (2005)
B‐cell‐deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis
M. Johansson (1997)
Immunological memory in B‐cell‐deficient mice conveys long‐lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells
M. Johansson (2001)
Prevalence of chlamydial and gonococcal infections among young adults in the United States.
W. Miller (2004)
The role that the functional Asp299Gly polymorphism in the toll-like receptor-4 gene plays in susceptibility to Chlamydia trachomatis-associated tubal infertility.
S. Morré (2003)
Induction of Protective Immunity against Chlamydia trachomatis Genital Infection by a Vaccine Based on Major Outer Membrane Protein–Lipophilic Immune Response-Stimulating Complexes
J. Igietseme (2000)
Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis
S. Yokoi (2004)
CD28 Costimulation and Parasite Dose Combine to Influence the Susceptibility of BALB/c Mice to Infection with Leishmania major1
H. L. Compton (2002)
IL-18 Enhances IL-4 Production by Ligand-Activated NKT Lymphocytes: A Pro-Th2 Effect of IL-18 Exerted Through NKT Cells1
M. Leite-de-Moraes (2001)
ICOS is essential for effective T-helper-cell responses
A. Tafuri (2001)
Factors influencing the induction of infertility in a mouse model of Chlamydia trachomatis ascending genital tract infection.
S. Pal (1998)
Characterization of Chlamydia trachomatis antigens with monoclonal and polyclonal antibodies.
I. Maclean (1988)
Cofactors in male-female sexual transmission of human immunodeficiency virus type 1.
F. Plummer (1991)
Immune response to the Chlamydia trachomatis outer membrane protein PorB.
D. Kawa (2004)
Effect of Toll‐Like Receptor (TLR) Agonists on TLR and Microbicide Expression in Uterine and Vaginal Tissues of the Mouse
G. Soboll (2006)
Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is this true for humans?
M. Johansson (1997)
Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls.
R. Bailey (1995)
The role of IFN-γ in the outcome of chlamydial infection
M. Rottenberg (2002)
Vaccination with the Chlamydia trachomatis Major Outer Membrane Protein Can Elicit an Immune Response as Protective as That Resulting from Inoculation with Live Bacteria
S. Pal (2005)
Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence.
W. Beatty (1994)
Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis.
T. Cain (1995)
The ADP-Ribosylating CTA1-DD Adjuvant Enhances T Cell-Dependent and Independent Responses by Direct Action on B Cells Involving Anti-Apoptotic Bcl-2- and Germinal Center-Promoting Effects1
L. Ågren (2000)
Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice
J. Lyons (2005)
Chlamydial infections in urology
F. Wagenlehner (2005)
Role of the CD28 receptor in T-cell activation.
C. June (1990)
Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars.
Y. Yuan (1989)
A Comparison of the Fallopian Tube's Response to Overt and Silent Salpingitis
D. Patton (1989)
Clearance of Chlamydia trachomatis– induced polyserositis in SCID mice requires both CD4+ and CD8+ cells
S. Thoma-Uszynski (1998)
Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes
R. Belland (2001)
A Novel Recombinant Multisubunit Vaccine against Chlamydia1
F. Eko (2004)
Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection
K. Fenton (2001)
Interaction between components of the type III secretion system of Chlamydiaceae.
A. Slepenkin (2005)
The long term follow-up of asymptomatic women with Chlamydia trachomatis
W. Chaim (2007)
Nitric oxide production: a mechanism of Chlamydia trachomatis inhibition in interferon-γ-treated RAW264.7 cells
B. Chen (1996)
Chlamydial vaccines--future trends.
M. E. Ward (1992)
Evolutionary relationships among eubacterial groups as inferred from GroEL (chaperonin) sequence comparisons.
A. Viale (1994)
Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
Kathryn A Skelding (2006)
Natural Killer T Cell Activation Protects Mice Against Experimental Autoimmune Encephalomyelitis
A. Singh (2001)
Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis.
M. Starnbach (1994)
Priming with Chlamydia trachomatis Major Outer Membrane Protein (MOMP) DNA followed by MOMP ISCOM Boosting Enhances Protection and Is Associated with Increased Immunoglobulin A and Th1 Cellular Immune Responses
Z. Dong-ji (2000)
Expression of the gene encoding protein A in Staphylococcus aureus and coagulase-negative staphylococci.
M. Uhlén (1984)
Cloning and characterization of inducible nitric oxide synthase from mouse macrophages.
Q. Xie (1992)
Demonstration of Chlamydia trachomatis IgG antibodies in the male partner of the infertile couple is correlated with a reduced likelihood of achieving pregnancy.
A. Idahl (2004)
Socio-demographic and behavioural factors associated with high incidence of sexually transmitted infections in female sex workers in Madagascar following presumptive therapy.
F. Behets (2005)
Truncated hemoglobin HbN protects Mycobacterium bovis from nitric oxide
H. Ouellet (2002)
α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria.
G. González-Aseguinolaza (2000)
CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract.
H. Su (1995)
Immunol. Cell Biol.
M. Fitzgerald (1995)
Human immune response and Chlamydia trachomatis infection.
D. Kunimoto (1985)
Global data on visual impairment in the year 2002.
S. Resnikoff (2004)
Mouse Inducible Costimulatory Molecule (ICOS) Expression Is Enhanced by CD28 Costimulation and Regulates Differentiation of CD4+ T Cells1
A. Mcadam (2000)
Lysosome repair enables host cell survival and bacterial persistence following Chlamydia trachomatis infection
W. Beatty (2007)
Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan
S. Girardin (2003)
Selective loss of the calcium ion signaling pathway in T cells maturing toward a T helper 2 phenotype.
J. Sloan-Lancaster (1997)
Lack of Cell Wall Peptidoglycan versus Penicillin Sensitivity: New Insights into the Chlamydial Anomaly
J. M. Ghuysen (1999)
Perinatal complications are associated with seropositivity for Chlamydia trachomatis during pregnancy.
K. Numazaki (1996)
Determination of neutralizing epitopes in variable domains I and IV of the major outer-membrane protein from Chlamydia trachomatis serovar K.
A. Villeneuve (1994)
Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways.
L. Perry (1997)
Autoimmunity to heat shock protein 60 and antigen-specific production of interleukin-10.
Y. Yi (1997)
Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
S. Pal (2006)
Induction of NO synthesis by lipoteichoic acid from Staphylococcus aureus in J774 macrophages: involvement of a CD14-dependent pathway.
Y. Hattor (1997)
In Situ Analysis of the Evolution of the Primary Immune Response in Murine Chlamydia trachomatis Genital Tract Infection
S. Morrison (2000)
Cytokine induced modulation of MHC class I and class II molecules on human cervical epithelial cells.
G. Ljunggren (1998)
Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells.
J. Mayer (1993)
Chlamydia trachomatis infection induces mucosal addressin cell adhesion molecule-1 and vascular cell adhesion molecule-1, providing an immunologic link between the fallopian tube and other mucosal tissues.
K. Kelly (2001)
Elevated serum Chlamydia trachomatis IgG antibodies. Association with decreased implantation rates in GIFT.
F. Sharara (1999)
Restricted Fusion of Chlamydia trachomatis Vesicles with Endocytic Compartments during the Initial Stages of Infection
M. Scidmore (2003)
Intranasal immunization with C. muridarum major outer membrane protein (MOMP) and cholera toxin elicits local production of neutralising IgA in the prostate.
D. Hickey (2004)
Genital Chlamydial Infections
J. Peipert (2003)
Effect of pelvic inflammatory disease on fertility.
L. Westrom (1995)
Chlamydia trachomatis Persistence in the Female Mouse Genital Tract: Inducible Nitric Oxide Synthase and Infection Outcome
K. Ramsey (2001)
Murine Oviduct Epithelial Cell Cytokine Responses to Chlamydia muridarum Infection Include Interleukin-12-p70 Secretion
R. M. Johnson (2004)
Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults*
A. Sutherland (2005)
Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit.
L. Ågren (1997)
Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis.
F. Eko (2003)
Human Nod1 Confers Responsiveness to Bacterial Lipopolysaccharides*
N. Inohara (2001)
Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity
M. Giuliani (1998)
Fc receptor regulation of protective immunity against Chlamydia trachomatis
T. Moore (2002)
CTLA-4 Engagement Inhibits Th2 but not Th1 Cell Polarisation
V. Ubaldi (2003)
Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response.
T. Darville (1997)
Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection.
J. Ito (1990)
CD28 costimulation prevents cell death during primary T cell activation.
P. J. Noel (1996)
Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens.
M. Holland (1993)
Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries.
L. Weström (1980)
Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response.
M. Johansson (1997)
CD8+ T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway.
P. Beatty (1994)
Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection.
K. Ramsey (1988)
Experimental Chlamydia trachomatis infection causes apoptosis in human sperm.
A. Satta (2006)
Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls
I. Apostolou (1999)
Endometrial Histopathology in Patients with Culture‐proved Upper Genital Tract Infection and Laparoscopically Diagnosed Acute Salpingitis
N. B. Kiviat (1990)
A Novel Polymorphism in the Toll-Like Receptor 2 Gene and Its Potential Association with Staphylococcal Infection
E. Lorenz (2000)
Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones.
J. Igietseme (1994)
IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection.
S. Wang (1999)
Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection.
R. Morrison (1995)
Immune Response to Chlamydial 60-Kilodalton Heat Shock Protein in Tears from Nepali Trachoma Patients
T. Hessel (2001)
Expression library immunization confers partial protection against Chlamydia muridarum genital infection.
C. L. McNeilly (2007)
A controlled trial of a human papillomavirus type 16 vaccine.
L. Koutsky (2002)
Risk factors for trachoma in Mali.
J. Schémann (2002)
Apoptosis of ejaculated human sperm is induced by co-incubation with Chlamydia trachomatis lipopolysaccharide.
A. Eley (2005)
Toll-Like Receptor-2, but Not Toll-Like Receptor-4, Is Essential for Development of Oviduct Pathology in Chlamydial Genital Tract Infection 1
T. Darville (2003)
Differential T cell costimulatory requirements in CD28-deficient mice.
A. Shahinian (1993)
Transcutaneous Immunization with Combined Cholera Toxin and CpG Adjuvant Protects against Chlamydia muridarum Genital Tract Infection
Linda J Berry (2004)
Antigen-dependent Proliferation of CD4+ CD25+ Regulatory T Cells In Vivo
L. Walker (2003)
CD1d Degradation in Chlamydia trachomatis-infected Epithelial Cells Is the Result of Both Cellular and Chlamydial Proteasomal Activity*
K. Kawana (2007)
Human Antibody Responses to a Chlamydia-Secreted Protease Factor
J. Sharma (2004)
DNA deaminating ability and genotoxicity of nitric oxide and its progenitors.
D. Wink (1991)
The Major Outer Membrane Protein of Chlamydia psittaci Functions as a Porin-Like Ion Channel
S. Wyllie (1998)
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma.
T. Anttila (2001)
Chlamydial IFN-γ immune evasion is linked to host infection tropism
D. Nelson (2005)
Genome and proteome analysis of Chlamydia.
B. B. Vandahl (2004)
Molecular mechanism of T‐cell control of Chlamydia in mice: role of nitric oxide in vivo
J. Igietseme (1996)
Differential Induction of Mucosal and Systemic Antibody Responses in Women After Nasal, Rectal, or Vaginal Immunization: Influence of the Menstrual Cycle1
P. Kozlowski (2002)
IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
P. Scott (1991)
Response of monkeys to immunization with cholera toxoid, toxin, and vaccine: reversion of cholera toxoid.
R. Northrup (1972)
Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
S. Singh (2006)
Semen quality of men with asymptomatic chlamydial infection.
Saeid Hosseinzadeh (2004)
DNA immunization with pgp3 gene of Chlamydia trachomatis inhibits the spread of chlamydial infection from the lower to the upper genital tract in C3H/HeN mice.
M. Donati (2003)
CARD4/Nod1 mediates NF‐κB and JNK activation by invasive Shigella flexneri
S. Girardin (2001)
Inducible Costimulator Protein Controls the Protective T Cell Response Against Listeria monocytogenes1
H. Mittrücker (2002)
This paper is referenced by
Mathematical Modelling of the Role of Mucosal Vaccine on the Within-host Dynamics of Chlamydia trachomatis.
Morenikeji Deborah Akinlotan (2020)